When did Medtronic report Q3 2025 earnings?

Medtronic (MDT) reported Q3 2025 earnings on February 18, 2025 before market open.

What were Medtronic's Q3 2025 revenue and EPS?

Medtronic reported revenue of $8.3B and diluted EPS of $1.39 for Q3 2025.

Did Medtronic beat estimates in Q3 2025?

Revenue missed the consensus estimate of $8.3B by $35.4M. EPS beat the consensus estimate of $1.36 by $0.03.

Where can I find Medtronic's Q3 2025 SEC filings?

You can read the 10-Q periodic report (0001613103-25-000022) directly on SEC EDGAR. The filing index links above go to sec.gov.

Medtronic MDT Q3 2025 earnings

Reported February 18, 2025 · Before market open

Revenue$8.3BMiss by $35.4M Diluted EPS$1.39Beat by $0.03

Revenue estimate$8.3B

EPS estimate$1.36

Next report

Aug 18, 2026 (in 2 months)

Revenue estimate$9.6B

EPS estimate$1.39

Financials

Q3 2025

Income statement

See full

Revenue$8.3B+2.5%

Gross profit$5.5B+3.9%

Operating income$1.6B+11.0%

Net income$1.3B-2.1%

EPS (diluted)$1.01+2.0%

Balance sheet

See full

Cash & equivalents$1.2B-23.6%

Total debt$26.7B+5.6%

Total equity$49.4B-4.6%

Total assets$90.0B-1.0%

Cash flow

See full

Operating cash flow$2.6B+4.0%

CapEx$476.0M+37.6%

Free cash flow$2.1B-1.5%

Valuation & ratios

Valuation

as of 01/24/25

See full

Market cap$116.46B0.0%

Enterprise value$141.87B+1.3%

P/E27.3×-0.4×

P/S3.5×-0.1×

Profitability

See full

Gross margin65.3%-0.2pp

Operating margin16.8%-0.7pp

Net margin12.8%-0.2pp

FCF margin16.5%+1.2pp

Returns & leverage

See full

Return on equity8.4%+0.3pp

Debt / equity0.5×+0.1×

Current ratio1.9×-0.4×

Segments

By segment

See full

Cardiovascular$3.0B+3.7%

Neuroscience$2.5B+4.4%

Medical Surgical$2.1B-1.9%

Diabetes$694.0M+8.4%

Other Operating Segments$34.3M—

By geography

See full

United States$4.2B—

Ireland$28.0M—

Versus estimates

Revenue

Q4 2026$9.8BBeat by $192.1M Q3 2026$9.0BBeat by $106.1M Q2 2026$9.0BBeat by $94.0M Q1 2026$8.6BBeat by $199.4M Q4 2025$8.9BBeat by $108.4M

Q3 2025$8.3BMiss by $35.4M

Diluted EPS

Q4 2026$0.96Miss by $0.58 Q3 2026$1.36Beat by $0.02 Q2 2026$1.36Beat by $0.05 Q1 2026$1.26Beat by $0.03 Q4 2025$1.62Beat by $0.04

Q3 2025$1.39Beat by $0.03

Ask the moment Medtronic reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Medtronic report Q3 2025 earnings?: Medtronic (MDT) reported Q3 2025 earnings on February 18, 2025 before market open.
What were Medtronic's Q3 2025 revenue and EPS?: Medtronic reported revenue of $8.3B and diluted EPS of $1.39 for Q3 2025.
Did Medtronic beat estimates in Q3 2025?: Revenue missed the consensus estimate of $8.3B by $35.4M. EPS beat the consensus estimate of $1.36 by $0.03.
Where can I find Medtronic's Q3 2025 SEC filings?: You can read the 10-Q periodic report (0001613103-25-000022) directly on SEC EDGAR. The filing index links above go to sec.gov.